X Bioscience PCL, formerly WOW Factor Public Company Limited, is a Thailand-based company. The Company is engaged in the business of investments. The Company is engaged in the food business with services delivering food experience of various nationalities to consumers in Thailand.

Employees

399

Sector

Financial & Commodity Market Operators

More about the company

Quotes

Date	Price	Change	Volume
21/08/26	THB 0.0700	0.00%	1,916,095
20/08/26	THB 0.0700	0.00%	3,247,800
19/08/26	THB 0.0700	-12.50%	8,576,100
18/08/26	THB 0.0800	0.00%	9,058,100
17/08/26	THB 0.0800	+14.29%	3,625,700

End-of-day quote Thailand S.E.

More quotes

End-of-day quote Thailand S.E. 21/08/2026			5-day change	1st Jan Change
0.0700 ^THB	0.00%		0.00%	-58.82%

08-17	X Bioscience Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT

Market Cap	851M 26.07M 22.33M 20.9M 19.13M 35.9M 2.49B 36.37M 247M 96.28M 1.25B 97.9M 95.77M 4.14B	P/E 2024	-2.62x	P/E 2025	-0.15x
Enterprise Value	1.09B 33.29M 28.52M 26.68M 24.42M 45.84M 3.19B 46.44M 315M 123M 1.6B 125M 122M 5.29B	EV / Sales 2024	4.31x	EV / Sales 2025	3.2x
Free-Float	8.16%	Yield 2024 *	-	Yield 2025	-

08-17	X Bioscience Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT
07-16	X Bioscience Public Company Limited Announces CEO Changes	CI
07-16	X Bioscience Public Company Limited Announces Executive Changes and Restructure of Executive Committees	CI
07-15	X Bioscience Subsidiary Disposes of Entire Stake in Eastern Cuisine (Thailand)	MT
07-07	X Bioscience Public Company Limited Approves Address Change	CI
06-03	X Bioscience Public Company Limited Announces Appointment of Ramjai Sriporamin to Chief Financial Officer, Effective June 1, 2026	CI
06-02	X Bioscience Public Company Limited Announces Board Changes	CI
05-18	X Bioscience says Q1 2026 net loss widens to THB 336.5 million from loss THB 52.8 million	RE
05-18	X Bioscience Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-18	X Bioscience Public Company Limited announced a financing transaction	CI
05-05	X Bioscience Public Company Limited Announces Resignation of Phurit Wongkham as Chief Operating Officer ? Food Division, Effective May 1, 2026	CI
04-27	X Bioscience appoints Ramjai Sriporaminas as CFO (acting)	RE

Current month	-12.50%
1 month	-12.50%
3 months	-12.50%
6 months	+16.67%
Current year	-58.82%

Wow Factor Stock

Stocks

XBIO

TH0753C10Z00

Financial & Commodity Market Operators

Valuation: Wow Factor

Chart: Wow Factor

Latest news : Wow Factor

Quotes and Performance

Course Extremes

Managers and Directors: Wow Factor

Other Financial & Commodity Market Operators

Financials

Company Profile

Quotes

1 week	0.06	0.08
1 month	0.06	0.09
Current year	0.04	0.18
1 year	0.04	2.87
3 years	0.04	6.79
5 years	0.04	35.35
10 years	0.04	147

Manager	Title	Age	Since
Amnart Lertpresertwong CEO	Chief Executive Officer	54	01/08/2026
Ramjai Sriporamin DFI	Director of Finance/CFO	-	27/04/2026
Anucha Ritpakdee CTO	Chief Tech/Sci/R&D Officer	-	01/05/2014

Director	Title	Age	Since
Sarayut Rueangsuwan BRD	Director/Board Member	43	16/05/2025
Supoj Pannoi CHM	Chairman	45	29/01/2026
Phurit Wongkham BRD	Director/Board Member	40	25/02/2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WOW FACTOR	0.00%	0.00%	-96.67%	-98.63%	26.07M
INTERCONTINENTAL EXCHANGE, INC.	+1.66%	+4.21%	-10.03%	+41.62%	90.52B
HONG KONG EXCHANGES AND CLEARING LIMITED	+0.77%	+3.59%	-4.79%	+49.08%	67.87B
DEUTSCHE BÖRSE AG	+1.18%	+3.66%	+9.57%	+75.17%	59.54B
LONDON STOCK EXCHANGE GROUP PLC	+0.70%	+0.77%	-9.17%	+6.62%	56.84B
NASDAQ, INC.	+0.69%	+1.24%	+4.53%	+89.65%	54.9B
SINGAPORE EXCHANGE LIMITED	-0.08%	-1.39%	+52.33%	+163.67%	20.95B
EURONEXT N.V.	+0.68%	+2.71%	+13.25%	+149.16%	19.33B
B3 S.A. - BRASIL, BOLSA, BALCÃO	-0.74%	+2.86%	+23.18%	+11.94%	14.62B
TMX GROUP LIMITED	+0.57%	-1.57%	-6.13%	+78.16%	10.51B
Average	+0.54%	-0.37%	-2.39%	+56.64%	39.51B
Weighted average by Cap.	+0.90%	+2.14%	+1.74%	+61.19%

	2024	2025
Net sales	319M 9.78M 8.37M 7.84M 7.17M 13.46M 935M 13.64M 92.57M 36.1M 470M 36.71M 35.91M 1.55B	130M 3.97M 3.4M 3.18M 2.91M 5.47M 380M 5.54M 37.6M 14.66M 191M 14.91M 14.58M 631M
Net income	-260M -7.97M -6.83M -6.39M -5.85M -10.97M -762M -11.12M -75.46M -29.43M -383M -29.92M -29.27M -1.27B	-469M -14.36M -12.3M -11.51M -10.53M -19.77M -1.37B -20.03M -136M -53.02M -690M -53.91M -52.74M -2.28B
Net Debt	345M 10.58M 9.06M 8.48M 7.76M 14.56M 1.01B 14.75M 100M 39.05M 508M 39.71M 38.85M 1.68B	236M 7.22M 6.18M 5.78M 5.3M 9.94M 691M 10.07M 68.34M 26.65M 347M 27.1M 26.51M 1.15B